Holen Sie sich die Stockscreener-App
9.98
0.10%
-0.010
Handel nachbörslich:
10.18
0.20
+2.00%
Drugs Made In America Acquisition Ii Corp Aktie (DMII) Neueste Nachrichten
MercadoLibre, Inc. Launches 2026 Long Term Retention Program for Key Employees (8-K Filing) - Minichart
Drugs Made In America Acquisition II Corp. Announces $1.4 Million Convertible Notes Financing Agreement with Alpha Multi Family Office - Minichart
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement - Investing.com Australia
Drugs Made In America II Issues Interim Convertible Note - TipRanks
Drugs Made In America Acquisition II Finalizes $1.4M Notes Deal, Adds $300K Interim Convertible - TradingView
$300K zero‑interest note backs Drugs Made In America II (NASDAQ: DMII) - stocktitan.net
Drugs Made in America Acquisition II Delays Annual Filing - TipRanks
Drugs Made in America Delays Annual Filing - TipRanks
Late 10-K notice — Drugs Made in America (NASDAQ: DMAA) delays FY2025 filing - Stock Titan
DMII (NASDAQ: DMII) files 12b-25—expects to file 10-K by Apr 15, 2026 - stocktitan.net
Drugs Made In America Acquisition II Corp.Right (NQ: DMIIR - FinancialContent
Pfizer Inc. - Britannica
FitLife Brands, Inc. 2025 Financial Performance: Online & Wholesale Revenue, Margins, and Strategic Initiatives - Minichart
Cambridge Acquisition Corp.: Performance & Quotes, CAQ Stock Price on Nasdaq Exchange - marketscreener.com
DMAAR Stock Price, News & Analysis - stocktitan.net
Market Rankings: Is Drugs Made In America Acquisition Corp Equity Rights growth already priced in2026 Fundamental Recap & Reliable Breakout Forecasts - baoquankhu1.vn
Entry Recap: Is Drugs Made In America Acquisition Corp affected by consumer sentimentTrade Volume Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Drugs Made In America Acquisition Corp. issues $100,000 convertible note as part of $500,000 financing - Investing.com Australia
Drugs Made in America (DMAA) seeks shareholder vote to extend SPAC deadline - Stock Titan
Drugs Made In America Signs Financing and Sponsor Deal - TipRanks
Drugs Made In America Acquisition Secures $500,000 Financing; Issues $100,000 Interim Note - TradingView
DMAAR SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
DMII Stock Price, News & Analysis - Stock Titan
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition Corp(DMAA) Holding History - GuruFocus
Newbridge Acquisition Limited: Performance & Quotes, NBRG Stock Price on Nasdaq Exchange - marketscreener.com
Take Profit: What analysts say about Drugs Made In America Acquisition Corp Equity Right stockPortfolio Performance Summary & Trade Opportunity Analysis - baoquankhu1.vn
Why Is Drugs Made In America Acquisition II Corp. Unit (DMIIU) Stock Down Today? - Meyka
Why Is Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Stock Down Today? - Meyka
14,375,000 Ordinary Shares of Drugs Made In America Acquisition II Corp. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
Drugs Made In America Acquisition Corp. announced that it expects to receive $0.5 million in funding from BV Advisory Partners, LLC - marketscreener.com
GigCapital9 Corp.: Performance & Quotes, GIX Stock Price on Nasdaq Exchange - marketscreener.com
Hudson Bay Capital Management LP Lowers Stock Holdings in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Guidance Update: Will Drugs Made In America Acquisition Corp Equity Right stock recover after earnings2026 Patterns & Entry Point Strategy Guides - baoquankhu1.vn
Drugs Made In America Acquisition II Secures Bridge Financing - TipRanks
Drugs Made In America Acquisition II Secures $150,000 Convertible Bridge Note From Alpha Multi Family Office - TradingView
DMII SEC FilingsDrugs Made In Amer Acq Ii Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Dow Update: Can Drugs Made In America Acquisition Corp Equity Right deliver alpha2026 Sector Review & Long-Term Safe Investment Plans - baoquankhu1.vn
Market Rankings: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growthPortfolio Performance Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Azimuth Capital Investment Management LLC Has $3.78 Million Holdings in Nestle SA $NSRGY - Defense World
Boothbay Fund Management LLC Purchases 28,695 Shares of Ryman Hospitality Properties, Inc. $RHP - Defense World
Boothbay Fund Management LLC Buys Shares of 138,963 Dianthus Therapeutics, Inc. $DNTH - Defense World
Boothbay Fund Management LLC Sells 70,000 Shares of Drugs Made In America Acquisition Corp. $DMAA - Defense World
DMIIRAI Stock Analysis - Meyka
Clear Street Group Inc. Acquires New Holdings in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
KCAC_u|Kensington Capital Acquisition VI Units (Proposed)|Price:10.050|Chg%:0.05 - TradingKey
GLED_u|GalaxyEdge Acquisition Units (Proposed)|Price:10.010| - TradingKey
MTAL_u|Metals Acquisition Unit (Proposed)|Price:10.180|Chg%:0.03 - TradingKey
Radcliffe Capital Management L.P. Has $5.42 Million Position in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Drugs Made In America Acq (DMAA) Stock Analysis Report | Financials & Insights - Benzinga Japan
Drugs Made In America Acquisition II Corp. Unit Stock Forecast Summary - Meyka
Will Drugs Made In America Acquisition Corp. stock benefit from upcoming earnings reportsJuly 2025 Momentum & Advanced Swing Trade Entry Plans - Naître et grandir
Can Drugs Made In America Acquisition Corp. Equity Right stock deliver surprise earnings beatWeekly Trend Recap & High Accuracy Investment Entry Signals - Naître et grandir
Aug Shorts: Is Drugs Made In America Acquisition Corp a momentum stockJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Drugs Made In America Acquisition II Corp. confirms trust account balance after review - Investing.com Australia
DMIIR Stock Price, Quote & Chart | DRUGS MADE IN AMERICA ACQ-RT (NASDAQ:DMIIR) - ChartMill
Support Test: Will Drugs Made In America Acquisition Corp. Equity Right stock outperform Dow Jones indexTrend Reversal & Accurate Buy Signal Alerts - Naître et grandir
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):